| U133 probe set | Gene description | Symbol | Location | GenBank reference | UniGene reference | SAM d-score | CBF Above/ Below mean | Fold change | |
| 1 | 206187_at | prostaglandin I2 (prostacyclin) receptor (IP) | PTGIR | Chr:19q13.3 | NM_000960 | Hs.458324 | 11.2 | Above | 4.3 |
| 2 | 205529_s_at | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | CBFA2T1 | Chr:8q22 | NM_004349 | Hs.90858 | 10.3 | Above | 13.7 |
| 3 | 205528_s_at | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | CBFA2T1 | Chr:8q22 | X79990 | Hs.90858 | 9.9 | Above | 19.6 |
| 4 | 206622_at | thyrotropin-releasing hormone | TRH | Chr:3q13.3-q21 | NM_007117 | Hs.182231 | 9.7 | Above | 14.4 |
| 5 | 204495_s_at | DKFZP434H132 protein | DKFZP434H132 | Chr:15q23 | NM_015492 | Hs.17936 | -9.6 | Below | 2.3 |
| 6 | 204494_s_at | DKFZP434H132 protein | DKFZP434H132 | Chr:15q23 | AW516789 | Hs.17936 | -9.2 | Below | 2.2 |
| 7 | 206090_s_at | disrupted in schizophrenia 1 | DISC1 | Chr:1q42.1 | NM_018662 | Hs.26985 | 8.7 | Above | 1.7 |
| 8 | 206940_s_at | POU domain, class 4, transcription factor 1 | POU4F1 | Chr:13q21.1-q22 | NM_006237 | Hs.458303 | 8.7 | Above | 16.6 |
| 9 | 34210_at | CDW52 antigen (CAMPATH-1 antigen) | CDW52 | Chr:1p36 | N90866 | Hs.276770 | 8.7 | Above | 3.5 |
| 10 | 211341_at | POU domain, class 4, transcription factor 1 | POU4F1 | Chr:13q21.1-q22 | L20433 | Hs.458303 | 8.5 | Above | 31.1 |
| 11 | 218825_at | EGF-like-domain, multiple 7 | EGFL7 | Chr:9q34.3 | NM_016215 | Hs.91481 | 8.4 | Above | 3.0 |
| 12 | 204661_at | CDW52 antigen (CAMPATH-1 antigen) | CDW52 | Chr:1p36 | NM_001803 | Hs.276770 | 8.3 | Above | 3.4 |
| 13 | 208891_at | dual specificity phosphatase 6 | DUSP6 | Chr:12q22-q23 | BC003143 | Hs.298654 | 8.2 | Above | 2.5 |
| 14 | 208893_s_at | dual specificity phosphatase 6 | DUSP6 | Chr:12q22-q23 | BC005047 | Hs.298654 | 8.2 | Above | 2.8 |
| 15 | 218858_at | hypothetical protein FLJ12428 | FLJ12428 | Chr:8q24.12 | NM_022783 | Hs.87729 | 8.1 | Above | 2.4 |
| 16 | 204811_s_at | calcium channel, voltage-dependent, alpha 2/delta subunit 2 | CACNA2D2 | Chr:3p21.3 | NM_006030 | Hs.389415 | 7.9 | Above | 5.3 |
| 17 | 204020_at | purine-rich element binding protein A | PURA | Chr:5q31 | BF739943 | Hs.29117 | -7.8 | Below | 2.5 |
| 18 | 218899_s_at | brain and acute leukemia, cytoplasmic | BAALC | Chr:8q22.3 | NM_024812 | Hs.169395 | 7.6 | Above | 3.8 |
| 19 | 211685_s_at | neurocalcin delta | NCALD | Chr:8q22-q23 | AF251061 | Hs.90063 | 7.6 | Above | 2.3 |
| 20 | 216831_s_at | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | CBFA2T1 | Chr:8q22 | AF018283 | Hs.90858 | 7.6 | Above | 21.4 |
| 21 | 208892_s_at | dual specificity phosphatase 6 | DUSP6 | Chr:12q22-q23 | BC003143 | Hs.298654 | 7.5 | Above | 2.2 |
| 22 | 212496_s_at | KIAA0876 protein | KIAA0876 | Chr:19p13.3 | BE256900 | Hs.301011 | 7.5 | Above | 2.2 |
| 23 | 220560_at | chromosome 11 open reading frame 21 | C11orf21 | Chr:11p15.5 | NM_014144 | Hs.272100 | -7.4 | Below | 3.0 |
| 24 | 221760_at | mannosidase, alpha, class 1A, member 1 | MAN1A1 | Chr:6q22 | BG287153 | Hs.255149 | 7.4 | Above | 3.7 |
| 25 | 209543_s_at | CD34 antigen | CD34 | Chr:1q32 | M81104 | Hs.374990 | 7.4 | Above | 3.2 |
| 26 | 212097_at | caveolin 1, caveolae protein, 22kDa | CAV1 | Chr:7q31.1 | AU147399 | Hs.74034 | 7.2 | Above | 9.1 |
| 27 | 206855_s_at | hyaluronoglucosaminidase 2 | HYAL2 | Chr:3p21.3 | NM_003773 | Hs.76873 | 7.1 | Above | 1.6 |
| 28 | 210010_s_at | solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 | SLC25A1 | Chr:22q11.21 | U25147 | Hs.111024 | 7.1 | Above | 1.9 |
| 29 | 219686_at | gene for serine/threonine protein kinase | HSA250839 | Chr:4p16.2 | NM_018401 | Hs.58241 | 7.0 | Above | 4.2 |
| 30 | 205173_x_at | CD58 antigen, (lymphocyte function-associated antigen 3) | CD58 | Chr:1p13 | NM_001779 | Hs.75626 | 7.0 | Above | 2.3 |
| 31 | 208978_at | cysteine-rich protein 2 | CRIP2 | Chr:14q32.3 | U36190 | Hs.70327 | 7.0 | Above | 4.2 |
| 32 | 219478_at | WAP four-disulfide core domain 1 | WFDC1 | Chr:16q24.3 | NM_021197 | Hs.36688 | 6.8 | Above | 2.8 |
| 33 | 216356_x_at | BAI1-associated protein 3 | BAIAP3 | Chr:16p13.3 | AB018277 | Hs.458427 | 6.8 | Above | 2.8 |
| 34 | 212136_at | ATPase, Ca++ transporting, plasma membrane 4 | ATP2B4 | Chr:1q25-q32 | AW517686 | Hs.343522 | -6.8 | Below | 1.7 |
| 35 | 208116_s_at | mannosidase, alpha, class 1A, member 1 | MAN1A1 | Chr:6q22 | NM_005907 | Hs.255149 | 6.8 | Above | 3.0 |
| 36 | 336_at | --- | --- | --- | D38081 | --- | 6.7 | Above | 1.9 |
| 37 | 203865_s_at | adenosine deaminase, RNA-specific, B1 (RED1 homolog rat) | ADARB1 | Chr:21q22.3 | NM_015833 | Hs.148822 | -6.7 | Below | 5.3 |
| 38 | 204021_s_at | purine-rich element binding protein A | PURA | Chr:5q31 | NM_005859 | Hs.29117 | -6.7 | Below | 2.9 |
| 39 | 219271_at | UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase T10 | GalNac-T10 | Chr:2p23.2 | NM_024572 | Hs.15830 | 6.7 | Above | 2.7 |
| 40 | 200989_at | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | HIF1A | Chr:14q21-q24 | NM_001530 | Hs.412416 | 6.6 | Above | 1.7 |
| 41 | 201968_s_at | phosphoglucomutase 1 | PGM1 | Chr:1p31 | NM_002633 | Hs.1869 | -6.6 | Below | 1.8 |
| 42 | 204285_s_at | phorbol-12-myristate-13-acetate-induced protein 1 | PMAIP1 | Chr:18q21.32 | AI857639 | Hs.96 | 6.6 | Above | 2.3 |
| 43 | 211744_s_at | CD58 antigen, (lymphocyte function-associated antigen 3) | CD58 | Chr:1p13 | BC005930 | Hs.75626 | 6.6 | Above | 2.4 |
| 44 | 221581_s_at | Williams-Beuren syndrome chromosome region 5 | WBSCR5 | Chr:7q11.23 | AF257135 | Hs.56607 | -6.5 | Below | 3.5 |
| 45 | 201137_s_at | major histocompatibility complex, class II, DP beta 1 | HLA-DPB1 | Chr:6p21.3 | NM_002121 | Hs.368409 | 6.5 | Above | 2.3 |
| 46 | 206631_at | prostaglandin E receptor 2 (subtype EP2), 53kDa | PTGER2 | Chr:14q22 | NM_000956 | Hs.2090 | 6.4 | Above | 1.9 |
| 47 | 204794_at | dual specificity phosphatase 2 | DUSP2 | Chr:2q11 | NM_004418 | Hs.1183 | 6.4 | Above | 2.8 |
| 48 | 221865_at | DKFZp547P234 protein | DKFZp547P234 | Chr:9q33.1 | BF969986 | Hs.170226 | 6.4 | Above | 1.7 |
| 49 | 204086_at | preferentially expressed antigen in melanoma | PRAME | Chr:22q11.22 | NM_006115 | Hs.30743 | 6.3 | Above | 3.3 |
| 50 | 212135_s_at | ATPase, Ca++ transporting, plasma membrane 4 | ATP2B4 | Chr:1q25-q32 | AW517686 | Hs.343522 | -6.3 | Below | 1.8 |
| 51 | 213194_at | hypothetical protein FLJ10539 | FLJ10539 | Chr:3p14.2 | BF059159 | Hs.301198 | 6.3 | Above | 7.8 |
| 52 | 218352_at | regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 | RCBTB1 | Chr:13q14 | NM_018191 | Hs.58452 | 6.3 | Above | 2.1 |
| 53 | 200665_s_at | secreted protein, acidic, cysteine-rich (osteonectin) | SPARC | Chr:5q31.3-q32 | NM_003118 | Hs.111779 | 6.3 | Above | 2.8 |
| 54 | 206726_at | prostaglandin D2 synthase, hematopoietic | PGDS | Chr:4q22.3 | NM_014485 | Hs.128433 | 6.3 | Above | 3.5 |
| 55 | 207375_s_at | interleukin 15 receptor, alpha | IL15RA | Chr:10p15-p14 | NM_002189 | Hs.12503 | 6.2 | Above | 2.1 |
| 56 | 204990_s_at | integrin, beta 4 | ITGB4 | Chr:17q11-qter | NM_000213 | Hs.85266 | 6.2 | Above | 3.0 |
| 57 | 212099_at | ras homolog gene family, member B | ARHB | Chr:2pter-p12 | AI263909 | Hs.406064 | 6.2 | Above | 2.6 |
| 58 | 212895_s_at | active BCR-related gene | ABR | Chr:17p13.3 | AL527773 | Hs.434004 | -6.2 | Below | 2.1 |
| 59 | 211991_s_at | major histocompatibility complex, class II, DP alpha 1 | HLA-DPA1 | Chr:6p21.3 | M27487 | Hs.914 | 6.2 | Above | 2.2 |
| 60 | 210744_s_at | interleukin 5 receptor, alpha | IL5RA | Chr:3p26-p24 | M75914 | Hs.68876 | 6.2 | Above | 6.8 |
| 61 | 205101_at | MHC class II transactivator | MHC2TA | Chr:16p13 | NM_000246 | Hs.126714 | 6.1 | Above | 2.4 |
| 62 | 203773_x_at | biliverdin reductase A | BLVRA | Chr:7p14-cen | NM_000712 | Hs.435726 | 6.1 | Above | 1.8 |
| 63 | 216942_s_at | CD58 antigen, (lymphocyte function-associated antigen 3) | CD58 | Chr:1p13 | D28586 | Hs.75626 | 6.1 | Above | 2.4 |
| 64 | 201497_x_at | myosin, heavy polypeptide 11, smooth muscle | MYH11 | Chr:16p13.13-p13.12 | NM_022844 | Hs.78344 | 6.1 | Above | 4.9 |
| 65 | 218742_at | protein related to Narf | HPRN | Chr:16p13.3 | NM_022493 | Hs.22158 | 6.1 | Above | 2.1 |
| 66 | 211031_s_at | cytoplasmic linker 2 | CYLN2 | Chr:7q11.23 | BC006259 | Hs.104717 | -6.1 | Below | 2.6 |
| 67 | 201700_at | cyclin D3 | CCND3 | Chr:6p21 | NM_001760 | Hs.83173 | -6.0 | Below | 1.9 |
| 68 | 203741_s_at | adenylate cyclase 7 | ADCY7 | Chr:16q12-q13 | NM_001114 | Hs.172199 | -6.0 | Below | 2.3 |
| 69 | 203932_at | major histocompatibility complex, class II, DM beta | HLA-DMB | Chr:6p21.3 | NM_002118 | Hs.1162 | 6.0 | Above | 2.1 |
| 70 | 218205_s_at | MAP kinase-interacting serine/threonine kinase 2 | MKNK2 | Chr:19p13.3 | NM_017572 | Hs.512094 | 6.0 | Above | 1.5 |
| 71 | 217989_at | retinal short-chain dehydrogenase/reductase 2 | RETSDR2 | Chr:4q22.1 | NM_016245 | Hs.282984 | 6.0 | Above | 1.4 |
| 72 | 211729_x_at | biliverdin reductase A | BLVRA | Chr:7p14-cen | BC005902 | Hs.435726 | 6.0 | Above | 1.7 |
| 73 | 202664_at | Wiskott-Aldrich syndrome protein interacting protein | WASPIP | Chr:2q31.2 | AW058622 | Hs.401414 | 6.0 | Above | 1.4 |
| 74 | 207134_x_at | tryptase beta 2 | TPSB2 | Chr:16p13.3 | NM_024164 | Hs.405479 | 6.0 | Above | 3.8 |
| 75 | 217795_s_at | hypothetical protein MGC3222 | MGC3222 | Chr:3p25.1 | W74580 | Hs.130330 | 6.0 | Above | 1.3 |
| 76 | 205760_s_at | 8-oxoguanine DNA glycosylase | OGG1 | Chr:3p26.2 | NM_016821 | Hs.380271 | -5.9 | Below | 2.3 |
| 77 | 219890_at | C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 5 | CLECSF5 | Chr:7q33 | NM_013252 | Hs.126355 | 5.9 | Above | 2.5 |
| 78 | 212495_at | KIAA0876 protein | KIAA0876 | Chr:19p13.3 | BE256900 | Hs.301011 | 5.9 | Above | 1.8 |
| 79 | 208178_x_at | triple functional domain (PTPRF interacting) | TRIO | Chr:5p15.1-p14 | NM_007118 | Hs.367689 | 5.9 | Above | 2.3 |
| 80 | 210613_s_at | synaptogyrin 1 | SYNGR1 | Chr:22q13.1 | BC000731 | Hs.414343 | 5.9 | Above | 1.7 |
| 81 | 33304_at | interferon stimulated gene 20kDa | ISG20 | Chr:15q26 | U88964 | Hs.105434 | 5.9 | Above | 2.0 |
| 82 | 218613_at | hypothetical protein DKFZp761K1423 | DKFZp761K1423 | Chr:8p22 | NM_018422 | Hs.236438 | 5.9 | Above | 2.7 |
| 83 | 221012_s_at | tripartite motif-containing 8 | TRIM8 | Chr:10q24.3 | NM_030912 | Hs.54580 | -5.8 | Below | 1.8 |
| 84 | 203355_s_at | ADP-ribosylation factor guanine nucleotide factor 6 | EFA6R | Chr:8pter-p23.3 | NM_015310 | Hs.408177 | 5.8 | Above | 3.5 |
| 85 | 205683_x_at | tryptase beta 2 | TPSB2 | Chr:16p13.3 | NM_003294 | Hs.405479 | 5.8 | Above | 3.5 |
| 86 | 221218_s_at | thiamin pyrophosphokinase 1 | TPK1 | Chr:7q34-q35 | NM_022445 | Hs.127548 | 5.8 | Above | 1.6 |
| 87 | 205330_at | meningioma (disrupted in balanced translocation) 1 | MN1 | Chr:22q11 | NM_002430 | Hs.268515 | 5.8 | Above | 2.8 |
| 88 | 202255_s_at | signal-induced proliferation-associated 1-like 1 | KIAA0440 | Chr:14q24.1 | NM_015556 | Hs.172180 | 5.8 | Above | 2.6 |
| 89 | 220668_s_at | DNA (cytosine-5-)-methyltransferase 3 beta | DNMT3B | Chr:20q11.2 | NM_006892 | Hs.251673 | -5.8 | Below | 2.5 |
| 90 | 204929_s_at | vesicle-associated membrane protein 5 (myobrevin) | VAMP5 | Chr:2p11.2 | NM_006634 | Hs.74669 | 5.7 | Above | 2.0 |
| 91 | 221497_x_at | egl nine homolog 1 (C. elegans) | EGLN1 | Chr:1q42.1 | BC005369 | Hs.130946 | 5.7 | Above | 1.8 |
| 92 | 218749_s_at | hypothetical protein FLJ22233 | FLJ22233 | Chr:12q24.21 | NM_024959 | Hs.286194 | -5.7 | Below | 1.8 |
| 93 | 216832_at | core-binding factor, runt domain, alpha subunit 2; translocated to, 1; cyclin D-related | CBFA2T1 | Chr:8q22 | AF018283 | Hs.90858 | 5.7 | Above | 1.8 |
| 94 | 202370_s_at | core-binding factor, beta subunit | CBFB | Chr:16q22.1 | NM_001755 | Hs.179881 | -5.7 | Below | 1.5 |
| 95 | 212706_at | DNA directed RNA polymerase II polypeptide J-related gene | POLR2J2 | Chr:7q11.22 | AB011110 | Hs.406505 | 5.7 | Above | 1.7 |
| 96 | 207081_s_at | phosphatidylinositol 4-kinase, catalytic, alpha polypeptide | PIK4CA | Chr:22q11.21 | NM_002650 | Hs.334874 | -5.7 | Below | 1.4 |
| 97 | 217080_s_at | homer homolog 2 (Drosophila) | HOMER2 | Chr:15q24.3 | Y19026 | Hs.93564 | 5.7 | Above | 1.9 |
| 98 | 203733_at | dexamethasone-induced transcript | DEXI | Chr:16p13.2 | NM_014015 | Hs.157925 | -5.7 | Below | 4.3 |
| 99 | 201473_at | jun B proto-oncogene | JUNB | Chr:19p13.2 | NM_002229 | Hs.400124 | 5.7 | Above | 2.0 |
| 100 | 217023_x_at | --- | --- | --- | AF099143 | --- | 5.7 | Above | 3.7 |